Sort
48,018 grants matching “immunotherapy”
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
$652,560Heike Elizabeth Daldrup-Link · Stanford University · U24 · FY2021 · CA
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE)
$652,534William E. Van Nostrand · University Of Rhode Island · R01 · FY2019 · NS
Accelerating Multi-modal Biomarker Discovery in Translational Research with Cloud Data Integration
$652,516David Craford · Cytobank, Inc. · R44 · FY2019 · GM
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
$652,473Heike Elizabeth Daldrup-Link · Stanford University · U24 · FY2025 · CA
Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9b in Patients with Prostate Cancer
$652,414Nupam P Mahajan · Washington University · R01 · FY2024 · CA
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence
$652,348Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2023 · NS
Innate Immunity Stimulation via CpG ODN in a Non-Human Primate Model of Sporadic Cerebral Amyloid Angiopathy
$652,338Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2020 · NS
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
$652,287Daniel J. Powell · University Of Pennsylvania · R01 · FY2023 · CA
Sex Differences in NK Cells Mediated by X-linked UTX
$652,282Maureen A Su · University Of California Los Angeles · R01 · FY2023 · AI
Sustaining antitumor effector CD8+ T cells for cancer therapy
$652,206Bin Zhang · Northwestern University At Chicago · R01 · FY2025 · CA
The role of brain resident T cells in Alzheimer's disease
$652,205Pamela Rosato · Dartmouth College · R01 · FY2023 · AG
The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy
$652,200Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · NS
Dissecting the role of CD8+ T cells in atherosclerosis
$652,158Chiara Giannarelli · New York University School Of Medicine · R01 · FY2024 · HL
Antigen-specific âkick and killâ of the latent HIV reservoir using dendritic cells
$652,156Robbie B Mailliard · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
$652,022Max Wintermark · Stanford University · R01 · FY2017 · CA
Image-guided ultrasound therapy and drug delivery in pancreatic cancer
$652,017Katherine W Ferrara · Stanford University · R01 · FY2018 · CA
Cancer Pharmacology
$651,936Lorraine J Gudas · Weill Medical Coll Of Cornell Univ · T32 · FY2022 · CA
Development of therapeutic chemokine-based formulations
$651,880Bira Arya · National Institute On Aging · ZIA · FY2015 · AG
Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma
$651,814Veronika Fedirko · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy
$651,539Alireza Faridar · Methodist Hospital Research Institute · R01 · FY2023 · AG
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy
$651,539Alireza Faridar · Methodist Hospital Research Institute · R01 · FY2024 · AG
Biology of R-Spondin-Induced Sensitization to Asparaginase in Colorectal Cancer
$651,421Alejandro Gutierrez · Boston Children'S Hospital · R01 · FY2021 · CA
Novel Health Equity Intervention to Improve Pediatric Oncology Outcome Disparities: Targeting Poverty and Psychosocial Stress
$651,395Kira O. Bona · Dana-Farber Cancer Inst · R01 · FY2022 · CA
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES
$651,363Mark A Herman · Baylor College Of Medicine · R01 · FY2021 · DK
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
$651,354Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2021 · CA